Good Fellow Healthcare Holdings Limited (HKG:8143)
Hong Kong · Delayed Price · Currency is HKD 0.1020
-0.0010 (-0.97%)
At close: Feb 13, 2026
HKG:8143 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 16.19 | 16.12 | 38.96 | 55.35 | 54.24 | 53.89 | |
Revenue Growth (YoY) | -30.45% | -58.63% | -29.61% | 2.06% | 0.65% | -62.73% |
Cost of Revenue | 7.66 | 7.75 | 20.29 | 28.34 | 27.58 | 27.44 |
Gross Profit | 8.52 | 8.37 | 18.67 | 27.01 | 26.66 | 26.45 |
Selling, General & Admin | 18.46 | 18.17 | 29.19 | 37.31 | 62.35 | 68.77 |
Other Operating Expenses | -0.3 | -0.08 | -0.12 | -0.04 | -1.77 | -2.62 |
Operating Expenses | 18.16 | 18.08 | 29.07 | 37.27 | 60.58 | 64.88 |
Operating Income | -9.64 | -9.71 | -10.39 | -10.26 | -33.92 | -38.43 |
Interest Expense | -0.04 | -0.19 | -0.31 | -0.41 | -1.66 | -2.35 |
Interest & Investment Income | 0 | 0 | 0.03 | 0.45 | 0.36 | 1.24 |
Currency Exchange Gain (Loss) | - | - | - | - | - | 0.13 |
Other Non Operating Income (Expenses) | -1.09 | -1.09 | 0.37 | 0.29 | 0.55 | - |
EBT Excluding Unusual Items | -10.76 | -10.99 | -10.3 | -9.94 | -34.66 | -39.41 |
Impairment of Goodwill | - | - | - | - | -6.11 | - |
Gain (Loss) on Sale of Investments | 0.04 | 0.08 | -0.44 | 0.11 | 1.54 | -0.57 |
Gain (Loss) on Sale of Assets | -7.82 | 2.64 | -2.08 | - | 31.68 | - |
Asset Writedown | - | - | -3.53 | -0.57 | - | - |
Legal Settlements | - | - | - | 4.56 | - | - |
Other Unusual Items | 0.9 | 0.9 | - | 0.19 | - | 0.58 |
Pretax Income | -17.64 | -7.37 | -16.34 | -5.65 | -7.55 | -39.4 |
Income Tax Expense | -0.02 | -0.01 | 1.04 | 0.03 | 1.32 | - |
Earnings From Continuing Operations | -17.62 | -7.36 | -17.39 | -5.68 | -8.87 | -39.4 |
Net Income to Company | -17.62 | -7.36 | -17.39 | -5.68 | -8.87 | -39.4 |
Minority Interest in Earnings | -2.78 | -2.77 | 0.28 | -0.2 | -3.82 | 9.22 |
Net Income | -20.4 | -10.13 | -17.11 | -5.88 | -12.69 | -30.18 |
Net Income to Common | -20.4 | -10.13 | -17.11 | -5.88 | -12.69 | -30.18 |
Shares Outstanding (Basic) | 1,147 | 583 | 583 | 583 | 583 | 583 |
Shares Outstanding (Diluted) | 1,147 | 583 | 583 | 583 | 583 | 583 |
Shares Change (YoY) | 96.62% | - | - | - | - | - |
EPS (Basic) | -0.02 | -0.02 | -0.03 | -0.01 | -0.02 | -0.05 |
EPS (Diluted) | -0.02 | -0.02 | -0.03 | -0.01 | -0.02 | -0.05 |
Free Cash Flow | -12.36 | 2.58 | -15.35 | -3.84 | -24.51 | -21.21 |
Free Cash Flow Per Share | -0.01 | 0.00 | -0.03 | -0.01 | -0.04 | -0.04 |
Gross Margin | 52.65% | 51.92% | 47.93% | 48.79% | 49.15% | 49.08% |
Operating Margin | -59.55% | -60.26% | -26.68% | -18.54% | -62.54% | -71.32% |
Profit Margin | -126.04% | -62.82% | -43.91% | -10.63% | -23.39% | -56.01% |
Free Cash Flow Margin | -76.35% | 16.01% | -39.38% | -6.94% | -45.18% | -39.35% |
EBITDA | -3.96 | -2.78 | -7.61 | -7.39 | -28.23 | -29.58 |
EBITDA Margin | -24.45% | -17.25% | -19.54% | -13.35% | -52.04% | -54.89% |
D&A For EBITDA | 5.68 | 6.93 | 2.78 | 2.87 | 5.69 | 8.86 |
EBIT | -9.64 | -9.71 | -10.39 | -10.26 | -33.92 | -38.43 |
EBIT Margin | -59.55% | -60.26% | -26.68% | -18.54% | -62.54% | -71.32% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.